For Us, It's About Total Specimen Integrity
Magnolia Medical Technologies is an innovative medical device company that develops, manufactures and sells blood and bodily fluid collection devices that significantly improve specimen integrity and the accuracy, consistency, and predictability of critical laboratory tests.
Decades of research show that false positive and false negative test results routinely lead to inappropriate and unnecessary treatments. Often times, these misdiagnoses significantly increase the use of powerful antibiotics which are associated with complications and extended patient length of stay as well as risk for hospital-acquired-infections and conditions.
Through groundbreaking device design, Magnolia Medical Technologies has become a provider ally and patient advocate. Our products mechanically eliminate human errors that cause preventable inaccurate test results, significantly improving patient safety and hospital care.
Steripath, our flagship product, is the only clinically proven technology to virtually eliminate the preventable error of blood culture contamination and false positive results for the diagnosis of sepsis – delivering sustained contamination rate as 0.2% with reduction in false positives of 92%.
We are unrelenting in our pursuit to improve current ‘standards of care’- constantly researching, testing and reinventing conventional processes in order to make the world of healthcare a better place.
Transforming Medical Care for Providers and Patients
We are focused on improving critical processes and technologies to deliver unprecedented efficiency, effectiveness, and optimal patient outcomes. With over 42 patents in our portfolio, we’ll keep innovating until we change the status quo.